| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |